• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Advertising
  • Contact Us
  • Subscribe
  • Events
Plastics Business

Plastics Business

Strategies for Today's Plastics Processors

  • Home
  • Articles
    • Article Archive
    • ENews Archive
    • Digital Archive
  • Advertising
    • Advertising Options
    • Media Kit
    • Editorial Calendar
    • Electronic Files
  • Buyers Guide
    • 2025 Buyers Guide Form
    • Buyers Guide
  • Subscribe
  • Video Vault
  • MAPP

Pacific Plastics Injection Molding Receives Medical Device Certification

Pacific Plastics Injection Molding (PPIM), a division of Diversified Plastics, Inc. (DPI), Vista, California, announced it has achieved ISO 13485:2016 certification for the medical device industry. ISO 13485 certification is part of the company’s growth initiative to meet the increased demand for medical device contract manufacturing.

ISO 13485:2016 is an international standard that details the requirements for a quality management system (QMS) specific to the medical device industry. To become ISO 13485 QMS certified, best practices in each step of a product’s life cycle must be demonstrated through quality management processes, including manufacturing, service and delivery.

“It is a testament to PPIM’s commitment to the highest safety and quality standards for medical device contract manufacturing,” said Pablo Soto, quality manager at PPIM. “Earning ISO 13485:2016 certification is a valuable achievement.”

Planned during the company’s 2021 expansion, PPIM is in preparation for the installation of a 1,500 sq. ft. cleanroom for plastic injection molding, as well as a white room for assembly and packaging. Combined, the DPI facility in Minnesota and the PPIM facility in California total 99,000 sq. ft. The Minnesota location also has two ISO Class 8 cleanrooms (Class 100,000) – one for micro injection molding.

PPIM and DPI have experience working with various medical-grade resins, including, but not limited, to PEEK, Ultem, polypropylene, polycarbonate and ABS. They include low- to large-volume production of endoscopes, pulse oximeters, surgical suture delivery devices, tabletop vital monitors, X-ray housings, wearable devices and more. The quality departments in both locations are well-informed in FDA 21 and CFR 820 specifications, which include IQ, OQ, PQs and other validation requirements.

For more information, visit www.pacificplastic.com.

Filed Under: Press Release Tagged With: Enews April 2023, News

Primary Sidebar

- Advertisement -

- Advertisement -



The Official Publication of Manufacturers Association for Plastics Processors
© 2026All Rights Reserved
Peterson Media Group | plasticsbusiness@petersonmg.com
785.271.5801
2150 SW Westport Dr., Suite 401, Topeka KS 66614